QuidelOrtho Projects Q1 Revenue Between $615M and $620M
summarizeSummary
QuidelOrtho Corp has issued first-quarter 2026 revenue guidance, projecting sales to be between $615 million and $620 million. This forward-looking financial update is highly material for investors, providing a crucial early indication of the company's performance following a challenging fiscal year 2025, which included a significant net loss and goodwill impairment. The projected quarterly revenue range represents a substantial figure relative to the company's market valuation. Traders will closely evaluate this guidance against current analyst expectations and await the official Q1 earnings report for further details on profitability and operational performance.
At the time of this announcement, QDEL was trading at $16.98 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $13.70 to $38.99. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.